96 related articles for article (PubMed ID: 20505362)
1. Checkpoint bypass and cell viability.
Chung JH; Zhang Y; Bunz F
Cell Cycle; 2010 Jun; 9(11):2102-7. PubMed ID: 20505362
[TBL] [Abstract][Full Text] [Related]
2. Human topoisomerase II function, tyrosine phosphorylation and cell cycle checkpoints.
Kaufmann WK
Proc Soc Exp Biol Med; 1998 Mar; 217(3):327-34. PubMed ID: 9492343
[TBL] [Abstract][Full Text] [Related]
3. Loss of p53 induces M-phase retardation following G2 DNA damage checkpoint abrogation.
Minemoto Y; Uchida S; Ohtsubo M; Shimura M; Sasagawa T; Hirata M; Nakagama H; Ishizaka Y; Yamashita K
Arch Biochem Biophys; 2003 Apr; 412(1):13-9. PubMed ID: 12646262
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle checkpoint function in bladder cancer.
Doherty SC; McKeown SR; McKelvey-Martin V; Downes CS; Atala A; Yoo JJ; Simpson DA; Kaufmann WK
J Natl Cancer Inst; 2003 Dec; 95(24):1859-68. PubMed ID: 14679155
[TBL] [Abstract][Full Text] [Related]
5. Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage.
Bačević K; Lossaint G; Achour TN; Georget V; Fisher D; Dulić V
Sci Rep; 2017 Oct; 7(1):13429. PubMed ID: 29044141
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle checkpoints and DNA repair preserve the stability of the human genome.
Kaufmann WK
Cancer Metastasis Rev; 1995 Mar; 14(1):31-41. PubMed ID: 7606819
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle checkpoint control mechanisms that can be disrupted in cancer.
Dash BC; El-Deiry WS
Methods Mol Biol; 2004; 280():99-161. PubMed ID: 15187251
[TBL] [Abstract][Full Text] [Related]
8. DNA damage and polyploidization.
Chow J; Poon RY
Adv Exp Med Biol; 2010; 676():57-71. PubMed ID: 20687469
[TBL] [Abstract][Full Text] [Related]
9. Antisense inhibition of Chk2/hCds1 expression attenuates DNA damage-induced S and G2 checkpoints and enhances apoptotic activity in HEK-293 cells.
Yu Q; Rose JH; Zhang H; Pommier Y
FEBS Lett; 2001 Sep; 505(1):7-12. PubMed ID: 11557032
[TBL] [Abstract][Full Text] [Related]
10. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
[TBL] [Abstract][Full Text] [Related]
11. 53BP1, a mediator of the DNA damage checkpoint.
Wang B; Matsuoka S; Carpenter PB; Elledge SJ
Science; 2002 Nov; 298(5597):1435-8. PubMed ID: 12364621
[TBL] [Abstract][Full Text] [Related]
12. Chk2 is required for optimal mitotic delay in response to irradiation-induced DNA damage incurred in G2 phase.
Rainey MD; Black EJ; Zachos G; Gillespie DA
Oncogene; 2008 Feb; 27(7):896-906. PubMed ID: 17684483
[TBL] [Abstract][Full Text] [Related]
13. Degradation of ATM-independent decatenation checkpoint function in human cells is secondary to inactivation of p53 and correlated with chromosomal destabilization.
Kaufmann WK; Campbell CB; Simpson DA; Deming PB; Filatov L; Galloway DA; Zhao XJ; Creighton AM; Downes CS
Cell Cycle; 2002; 1(3):210-9. PubMed ID: 12429935
[TBL] [Abstract][Full Text] [Related]
14. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
15. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of cytotoxicity of topoisomerase i poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe.
Tse AN; Schwartz GK
Cancer Res; 2004 Sep; 64(18):6635-44. PubMed ID: 15374978
[TBL] [Abstract][Full Text] [Related]
17. The G(2) DNA damage checkpoint delays expression of genes encoding mitotic regulators.
Crawford DF; Piwnica-Worms H
J Biol Chem; 2001 Oct; 276(40):37166-77. PubMed ID: 11483598
[TBL] [Abstract][Full Text] [Related]
18. p53 regulates a G2 checkpoint through cyclin B1.
Innocente SA; Abrahamson JL; Cogswell JP; Lee JM
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2147-52. PubMed ID: 10051609
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between DNA damage and cell survival checkpoints during G2 and mitosis: pharmacologic implications.
Bozko P; Sabisz M; Larsen AK; Skladanowski A
Mol Cancer Ther; 2005 Dec; 4(12):2016-25. PubMed ID: 16373717
[TBL] [Abstract][Full Text] [Related]
20. p53-dependent signaling sustains DNA replication and enhances clonogenic survival in 254 nm ultraviolet-irradiated human fibroblasts.
Cistulli CA; Kaufmann WK
Cancer Res; 1998 May; 58(9):1993-2002. PubMed ID: 9581844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
